Author:
Haque Wasim,Fareed Jawed,Wehrmacher William H.,Messmore Harry L.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Zhang J, De of cycylooxygenase 2 inhibitors on renal and arhythmia events, JAMA 2006;296:1619–1632.
2. Graham DJ, COX-2 inhibitors, other NSAIDS, and cardiovascular risk: the seduction of common sense, JAMA 2006;296:1653–1656.
3. Sooriakumaran P. COX-2 inhibitors and the heart: are all coxibs the same?, Post Grad Med J 2006;82:242–245.
4. Heim HK, Broich K. Selective COX-2 inhibitors and risk of thromboembolic e4vents-regulatory aspects. Thromb Haemost 2006;96:423–432.
5. Hankey JG, Eikelboom JW. Cyclooxygenase 2 inhibitors: are they really atherothrombotic, and, if not, why not? Stroke 2003;34:2376–2340.